Medical Condition

septic shock

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 3, Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for septic shock sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — septic shock Clinical Trials

How many clinical trials are currently recruiting for septic shock?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for septic shock, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for septic shock?

septic shock research spans Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a septic shock clinical trial?

Eligibility criteria for septic shock trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Top Sponsors

Centre Hospitalier Universitaire, Amiens 2 trials

Mahidol University 1 trial

Assistance Publique - Hôpitaux de Paris 1 trial

Helwan University 1 trial

University of Manitoba 1 trial

Recruiting Clinical Trials

NCT06937918

Recruiting

Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study

Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure

Assistance Publique - Hôpitaux...

View Trial →

NCT07530146 Phase 3

Recruiting

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock

Centre Hospitalier Universitai...

View Trial →

NCT07203833

Recruiting

Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock

Centre Hospitalier Universitai...

View Trial →

NCT05093075 Phase 2

Recruiting

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

University of Manitoba

View Trial →

NCT06570187 Phase 4

Recruiting

The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients

Xanthohumol as an Adjuvant in the Treatment of Septic Shock

Medical University of Lublin

View Trial →

NCT07539883

Recruiting

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

Seoul National University Bund...

View Trial →

NCT07343206

Recruiting

Early Norepinephrine Administration and Rapid Dose Adjustment

The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock

Avicenna Military Hospital

View Trial →

NCT07273526

Recruiting

Adrenaline V/s Dopamine in Fuid Refractory Septic Shock

Related Conditions

sepsis (3) pneumonia (2) critical illness (1) fluid over load (1) dynamic arterial elastance (1) cardiogenic shock (1) postresuscitation disease (1) the critically ill patient is requiring intubation (1) calcium sensing receptor (1) calcium phosphate disorders (1) inflammation (1) monocyte (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology